Quest Diagnostics Incorporated

DGX·NYSE·Healthcare
Compare
232.63+1.66 (+0.72%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours232.630.00 (0.00%)Oct 12, 4:39 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close230.97
Open228.66
Day range231.42234.64
52-week range171.18248.84
Off day high−0.86%
Off 52-week high−6.51%
Volume865.23K
Avg. volume (3M)1.05M
Market cap25.68B
EPS (TTM)9.42
Forward P/E19.33
P/E ratio (TTM)24.70
Dividend yield1.49% (3.44)
Beta (5Y)0.54
Shares outstanding110.37M
Short interest3.11% of float
Earnings dateOct 22, 2026
Analyst target248.80
Profit margin9.19%

Against its peers

Compare in full ›
DGX LH ICLR RVTY IDXX NTRA
Market cap 25.68B 25.59B 12.68B 17.36B 41.28B 57.34B
P/E (TTM) 24.7 26.1 173.1 74.5 36.8 —
Forward P/E 19.3 16.0 13.9 26.4 31.3 -2,014.0
Price/book 3.4 3.0 1.4 2.4 25.6 31.4
Dividend yield 1.49% 0.92% — 0.18% — —
1-year change +26.37% +12.84% −11.76% +69.47% −18.21% +130.07%
Today +0.72% +1.08% +0.14% +0.93% +1.15% −0.73%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.

Latest news

All DGX news ›
Pluang·

Quest Diagnostics Inc (DGX) Stock Price Today

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance…

BioSpace·Positive

Insulet Announces Omnipod Discover Now Available in U.S.

Web-based data platform turns Omnipod 5 data into clear, personalized insights for users, caregivers, and healthcare professionals "The future of diabetes care is not just about generating more data, it's about making that data…

The Independent·

Become an Independent member to bookmark this article

New prescription changes for millions of NHS app users The Independent New prescription changes for millions of NHS app users - NHS app users in England can now receive smartwatch and smartphone notifications when their prescriptions are…

@kalkineus·Positive

Quest Diagnostics (NYSE:DGX) Rides Steady Testing Demand

News Corp Submits ASX Daily Stock Buyback Reports for October 5, 2026 Policy changes affecting research funding and drug pricing continue to influence customer budgets. Funding conditions for early-stage biotechnology remain tight as…

Zacks Investment Research·Positive

All You Need to Know About Quest Resource (QRHC) Rating Upgrade to Buy

Quest Resource (QRHC Quick QuoteQRHC - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most…

From articles in the 4Search news index.

In the news

21mentions in 30 days
15with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.